** Hong Kong-listed shares of WuXi Biologics jump 8.3% to HK$20.30, and are third-biggest pct gainers in the benchmark Hang Seng Index
** WuXi Biologics and WuXi AppTec are planning to sell some of their operations after the Chinese biotech companies were targeted by the U.S. on national security grounds, the Financial Times reported on Thursday
** WuXi Biologics and WuXi AppTec did not immediately respond to Reuters' requests for a comment
** The U.S. House of Representatives passed a bill last month aiming to restrict business with China's WuXi AppTec and several other biotech companies on national security grounds
** Hong Kong stock of WuXi AppTec jumps 7.3% to HK$64.55, and is fourth-biggest pct gainer in Hang Seng Index
, which is up 0.4%
** Hang Seng Commerce & Industry Index gains 0.8%, and healthcare index rises 1.7%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。